Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Management of Severely Uncontrolled Type 2 Diabetes

Patient Assessment and Current Regimen

  • A 39-year-old female patient with over 20 years of diabetes history has an HbA1c level of 12.5% and glucose in her urine, indicating poorly controlled diabetes, with a current regimen of sitagliptin, insulin glargine, and NovoLOG 3, 2
  • The patient's current regimen includes sitagliptin 50mg, insulin glargine (40 units at bedtime, 10 units AM), and NovoLOG with a sliding scale (max 36 units/day), with a BMI of 24.4 and well-controlled hypertension 4
  • The American Diabetes Association recommends intensifying insulin therapy for patients with HbA1c levels ≥10-12%, especially with symptoms of hyperglycemia, starting with a structured basal-bolus insulin regimen 1, 2
  • Transitioning to a structured basal-bolus insulin regimen is recommended, continuing insulin glargine as basal insulin and implementing fixed mealtime dosing of NovoLOG (insulin aspart) 4, 2
  • Initial mealtime insulin dosing should be 0.1-0.2 units/kg per meal, with a total daily insulin requirement of approximately 0.8-1.0 units/kg/day for severely uncontrolled diabetes 2, 1

Medication Adjustments and Insulin Dose Titration

  • Discontinuing sitagliptin is recommended as it provides minimal benefit when using multiple daily insulin injections, and considering adding an SGLT2 inhibitor to improve glucose control and potentially reduce total daily insulin dose 2
  • Basal insulin adjustment should be increased by 2-4 units every 3-4 days until fasting glucose is consistently <130 mg/dL, with frequent blood glucose monitoring at least 4 times daily (before meals and at bedtime) 2, 1

Monitoring and Follow-up

  • Follow-up within 1-2 weeks is recommended to assess response and adjust insulin doses, with repeat HbA1c in 3 months to evaluate effectiveness of the regimen 3, 4
  • Monitoring for hypoglycemia is crucial, especially with intensified insulin regimen 1, 2